These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 11242518

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion.
    Dimitrov AS, Rawat SS, Jiang S, Blumenthal R.
    Biochemistry; 2003 Dec 09; 42(48):14150-8. PubMed ID: 14640682
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A large HIV gp41 construct with trimer-of-hairpins structure exhibits V2E mutation-dominant attenuation of vesicle fusion and helicity very similar to V2E attenuation of HIV fusion and infection and supports: (1) hairpin stabilization of membrane apposition with larger distance for V2E; and (2) V2E dominance by an antiparallel β sheet with interleaved fusion peptide strands from two gp41 trimers.
    Rokonujjaman M, Sahyouni A, Wolfe R, Jia L, Ghosh U, Weliky DP.
    Biophys Chem; 2023 Feb 09; 293():106933. PubMed ID: 36508984
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A leucine zipper-like sequence from the cytoplasmic tail of the HIV-1 envelope glycoprotein binds and perturbs lipid bilayers.
    Kliger Y, Shai Y.
    Biochemistry; 1997 Apr 29; 36(17):5157-69. PubMed ID: 9136877
    [Abstract] [Full Text] [Related]

  • 28. A novel bispecific peptide HIV-1 fusion inhibitor targeting the N-terminal heptad repeat and fusion peptide domains in gp41.
    Jiang X, Jia Q, Lu L, Yu F, Zheng J, Shi W, Cai L, Jiang S, Liu K.
    Amino Acids; 2016 Dec 29; 48(12):2867-2873. PubMed ID: 27631437
    [Abstract] [Full Text] [Related]

  • 29. How structure correlates to function for membrane associated HIV-1 gp41 constructs corresponding to the N-terminal half of the ectodomain.
    Sackett K, Shai Y.
    J Mol Biol; 2003 Oct 10; 333(1):47-58. PubMed ID: 14516742
    [Abstract] [Full Text] [Related]

  • 30. The role of the N-terminal heptad repeat of HIV-1 in the actual lipid mixing step as revealed by its substitution with distant coiled coils.
    Wexler-Cohen Y, Sackett K, Shai Y.
    Biochemistry; 2005 Apr 19; 44(15):5853-61. PubMed ID: 15823044
    [Abstract] [Full Text] [Related]

  • 31. Identification of membrane-active regions of the HIV-1 envelope glycoprotein gp41 using a 15-mer gp41-peptide scan.
    Moreno MR, Pascual R, Villalaín J.
    Biochim Biophys Acta; 2004 Feb 10; 1661(1):97-105. PubMed ID: 14967479
    [Abstract] [Full Text] [Related]

  • 32. Conformational mapping of the N-terminal peptide of HIV-1 gp41 in lipid detergent and aqueous environments using 13C-enhanced Fourier transform infrared spectroscopy.
    Gordon LM, Mobley PW, Lee W, Eskandari S, Kaznessis YN, Sherman MA, Waring AJ.
    Protein Sci; 2004 Apr 10; 13(4):1012-30. PubMed ID: 15044732
    [Abstract] [Full Text] [Related]

  • 33. Solid-state nuclear magnetic resonance measurements of HIV fusion peptide 13CO to lipid 31P proximities support similar partially inserted membrane locations of the α helical and β sheet peptide structures.
    Gabrys CM, Qiang W, Sun Y, Xie L, Schmick SD, Weliky DP.
    J Phys Chem A; 2013 Oct 03; 117(39):9848-59. PubMed ID: 23418890
    [Abstract] [Full Text] [Related]

  • 34. Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region.
    Eckert DM, Kim PS.
    Proc Natl Acad Sci U S A; 2001 Sep 25; 98(20):11187-92. PubMed ID: 11572974
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Functional and structural characterization of HIV-1 gp41 ectodomain regions in phospholipid membranes suggests that the fusion-active conformation is extended.
    Korazim O, Sackett K, Shai Y.
    J Mol Biol; 2006 Dec 15; 364(5):1103-17. PubMed ID: 17045292
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Hydrophobic mutations in buried polar residues enhance HIV-1 gp41 N-terminal heptad repeat-C-terminal heptad repeat interactions and C-peptides' anti-HIV activity.
    Zheng B, Wang K, Lu L, Yu F, Cheng M, Jiang S, Liu K, Cai L.
    AIDS; 2014 Jun 01; 28(9):1251-60. PubMed ID: 24625369
    [Abstract] [Full Text] [Related]

  • 39. HIV-1 membrane fusion mechanism: structural studies of the interactions between biologically-active peptides from gp41.
    Lawless MK, Barney S, Guthrie KI, Bucy TB, Petteway SR, Merutka G.
    Biochemistry; 1996 Oct 22; 35(42):13697-708. PubMed ID: 8885850
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.